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ABSTRACT
Objective: Assess the current BCG vaccination
policies and delivery pathways for immunisation in
Primary Care Trusts (PCTs) in England since the 2005
change in recommendations.
Design: A survey of key informants across PCTs using
a standardised, structured questionnaire.
Setting: 152 PCTs in England.
Results: Complete questionnaires were returned from
127 (84%) PCTs. Sixteen (27%) PCTs reported
universal infant vaccination and 111 (73%) had
selective infant vaccination. Selective vaccination
outside infancy was also reported from 94 (74%)
PCTs. PCTs with selective infant policy most frequently
vaccinated on postnatal wards (51/102, 50%), whereas
PCTs with universal infant vaccination most frequently
vaccinated in community clinics (9/13, 69%; p=0.011).
To identify and flag up eligible infants in PCTs with
targeted infant immunisation, those who mostly
vaccinate on postnatal wards depend on midwives and
maternity records, whereas those who vaccinate
primarily in the community rely more often on various
healthcare professionals.
Conclusions: Targeted infant vaccination has been
implemented in most PCTs across the UK. PCTs with
selective infant vaccination provide BCG vaccine via a
greater variety of healthcare professionals than those with
universal infant vaccination policies. Data on vaccine
coverage would help evaluate the effectiveness of
delivery. Interruptions of delivery noted here emphasise
the importance of not just an agreed, standardised, local
pathway, but also a named person in charge.
INTRODUCTION
Tuberculosis (TB) remains a public health
problem in England. After a century of con-
sistent decline in the incidence and annual
infection risk, the incidence of TB has been
rising since the late 1980s.1 TB is concen-
trated within certain groups of the population
(including migrants from high-prevalence
countries, prisoners, homeless persons and
other marginal populations) and in urban
areas.2
Since the 1950s, immunisation with the
BCG vaccine, which has been shown to be
highly effective in the UK population,3 has
been a part of TB control efforts in England.
The routine policy had been primarily to
administer the BCG vaccine to all tuberculin-
negative schoolchildren aged 10–14 years. In
some areas BCG was given during infancy
and it was recommended that it should also
be given to ‘children of immigrants in whose
communities there is a high incidence of
TB’, among other high-risk groups.4 In 2005,
this policy was replaced by a targeted immun-
isation programme directed at children with
high risk of TB exposure.
The change in policy came after several
years of discussion in the independent gov-
ernment advisory committee, the Joint
Committee of Vaccination and Immunisation
( JCVI). In the 1990s, it was estimated that
due to the low TB incidence, universal school-
age vaccination was no longer cost-effective.5
Universal BCG vaccination, however,
remained policy largely because the inci-
dence was rising slowly and health authorities
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were unsure about the impact that the emerging HIV epi-
demic could have on TB epidemiology.5 6 In 2005, after
the HIV epidemic had stabilised and the UK had already
fulﬁlled the criteria of the International Union Against
Tuberculosis and Lung Diseases (IUATLD) to stop
routine immunisation (which recommends different pol-
icies for different levels of TB, based on economic apprai-
sals and the balance between the beneﬁts and risks of
BCG vaccination),7 the JCVI recommended stopping uni-
versal school-age vaccination and replacing it with a tar-
geted infant vaccination programme.5
As part of this targeted infant programme, it is agreed
that universal vaccination is the most effective way to
reach all eligible children in areas of the country with
TB incidence ≥40 per 100 000 person-years (pyrs). In
areas with TB incidence <40 per 100 000 pyrs, a selective
approach is recommended to immunise only infants at
high risk, that is, if their parents or grandparents origin-
ate from a country with an incidence ≥40 per 100 000
pyrs, if travelling to a high-incidence country for 3 or
more months or when in contact with a TB case. In add-
ition, children of any age at high risk of TB should be
vaccinated at suitable opportunities.8
In view of possible organisational changes in the NHS
and given the current TB epidemiology in the country,
we considered it important and timely to assess the BCG
vaccine policy and the main vaccine delivery pathways
across the commissioning bodies for community and
hospital care (Primary Care Trusts, PCTs) in England.
METHODS
A standardised, mostly closed-ended structured question-
naire was designed (available from the authors). The
questionnaire covered the vaccination policy inside and
outside infancy, eligibility criteria and their documenta-
tion, delivery pathways and constraints to service deliv-
ery. The questionnaire was piloted in four London PCTs.
In November 2010, we contacted all 152 PCTs in
England. Immunisation leads and other staffs involved
in TB control and BCG vaccination implementation
were electronically mailed a copy of the questionnaire
and a web-link to an internet equivalent created using
the survey engine SurveyMonkey. As delivery of BCG
vaccine involves a chain of activities and responsibilities,
respondents were asked to gather information from
other key informants as needed. A reminder was sent
after 4 weeks. After an additional 4 weeks, we contacted
non-respondent PCTs by telephone to gather the infor-
mation required.
At completion of the active data collection, as an add-
itional data check, between August 2011 and September
2011, we searched PCTs’ websites and related NHS
sources for publicly available documents on their
current BCG vaccination policy. We assessed the agree-
ment between the information on these publicly avail-
able documents and the data collected from the survey.
We compared distribution frequencies using a χ2 test or
Fisher’s exact test where appropriate. For each variable,
we only included observations for which data were
available.
RESULTS
Between November 2010 and March 2011, 123 question-
naires representing 129/152 PCTs (85%) were returned:
72 (59%) as electronic documents and 51 (41%) via the
internet survey. No difference in TB notiﬁcation rates was
found between responding and non-responding PCTs
(data not presented). We found publically available
current BCG policy documents for 114 (88%) of the 129
PCTs. Two (2%) PCTs were excluded from subsequent
analysis because their BCG policy could not be deter-
mined from the responses. Sixteen (13%) PCTs reported
universal infant vaccination and 111 (87%) selective
infant vaccination. The agreement with publically avail-
able BCG policy documents was high, with only three
(2%) PCTs reporting a policy that was different from the
information in these documents. Responses from these
three PCTs to more detailed questions in the question-
naire were consistent with a selective infant vaccination at
that time.
Three PCTs reported changing their policy between
2006 and 2011; one PCT followed the national recom-
mendation and changed from targeted infant vaccin-
ation to universal infant vaccination as TB incidence
exceeded 40 per 100 000 pyrs; one PCT changed to uni-
versal infant vaccination, although their TB incidence
was <40 per 100 000 pyrs but justiﬁed doing so because
of a borderline TB rate, high TB rates in neighbouring
areas and high population mobility; one PCT had a uni-
versal infant vaccination programme prior to 2006,
although their TB incidence was below the threshold,
and changed to targeted infant vaccination.9
Some PCTs reported vaccination policies that did not
reﬂect the JCVI recommendations. Six PCTs reported tar-
geted infant vaccination despite having a 3-year average
TB incidence ≥40 per 100 000.9 Documents obtained
from the websites, however, of three of these PCTs, state
that they implement universal infant BCG vaccination.
Six of the 16 PCTs reporting universal vaccination had
3-year average TB incidence ≤40 per 100 000.9 They were
all in or close to major conurbations.
Vaccination during infancy
PCTs with a selective infant BCG vaccination policy
administer BCG via a wider range of healthcare provi-
ders than PCTs with universal infant BCG vaccination
(table 1). PCTs with selective policy most frequently
offer vaccination on postnatal wards (51/102, 50%) but
also vaccinate in community (24/102, 24%) and hospital
clinics (27/102, 26%); PCTs with universal policy more
frequently offer vaccination in community clinics (9/13,
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69%) and less frequently on postnatal wards (4/13,
31%, p=0.011).
All PCTs that vaccinate primarily on postnatal wards
do so during the infants’ ﬁrst month of life, whereas
only 13/37 (35%) PCTs that mainly vaccinate in commu-
nity clinics do so in the infants’ ﬁrst month of life
(p<0.001).
BCG vaccination receipt in infancy is documented in
various ways across PCTs, and this did not depend on
the vaccination policy (table 1). It is most consistently
documented in the Red Book (119/123, 97%) and in
the Child Health Information Systems (114/123, 93%).
It is also noted in other registers and notes (table 1),
but always in combination with either or both of the
former two (ﬁgure 1).
Selective infant vaccination
In the 111 PCTs with selective infant vaccination, 71%
reported routinely assessing eligibility for BCG. They all
offer BCG vaccination to children with parents or grand
parents born in countries with TB incidence ≥40 per
100 000 pyrs (table 2). Six PCTs reported that travel to a
high-incidence country for 3 or more months is not an
eligibility criterion; and two PCTs reported that contact
with a TB case is not a selection criterion either.
Two main BCG delivery pathways were apparent from
the information on identiﬁcation and primary place of
immunisation, but with considerable overlap. Where
midwives are primarily responsible for identifying eligible
infants, they are more frequently vaccinated on postnatal
wards (37/56, 66%) than when eligibility is ﬂagged by
general practitioners (GPs), health visitors (HVs) or pae-
diatricians (12/44, 27%; p<0.001). Conversely, in PCTs in
which eligible infants are primarily ﬂagged up by GPs,
HVs or paediatricians, they are more frequently vacci-
nated in community clinics (32/44, 73%) than when
midwives identify them (19/56, 34%; p<0.001). In line
with these delivery pathways, when infants are identiﬁed
by midwives or vaccinated on postnatal wards, their eligi-
bility is most frequently ﬂagged up in maternity records,
whereas when infants are identiﬁed by GPs, HVs or pae-
diatricians or when they are vaccinated in community
clinics, various systems are used with no clear preference
(table 3).
Vaccination outside of infancy
Vaccination outside infancy was reported in 94/127
(74%) PCTs. In 14/94 (14%) PCTs vaccination outside
of infancy is offered to preschool children only, in 9/94
Figure 1 Principal systems used to document BCG
vaccination and their combinations in Primary Care Trusts
with infant vaccination policy (N=123).
Table 2 Selection criteria employed to decide eligibility
for BCG vaccination in 111 Primary Care Trusts with a
targeted infant vaccination policy
n (%)*
Infant of parents born in country with incidence
>40 per 100000
107 (100)
Contact with TB 93 (87)
Prolonged travel 94 (88)
Parental request 14 (13)
Insecure accommodation 13 (12)
Socially deprived 2 (2)
Asylum seeker/refugees 2 (2)
*Four observations with missing data.
TB, tuberculosis.
Table 1 Place where BCG is primarily administered and
systems reported to document BCG vaccination in 127
Primary Care Trusts with infant vaccination policy
Selective
infant
vaccination
Universal
infant
vaccination
n (%) n (%)
Place of primary BCG
administration
N=102* N=13**
Postnatal ward 51 (50) 4 (31)
At home 0 0
At community clinic 24 (23) 9 (69)
At chest clinic 17 (17) 0
At hospital paediatric clinic 10 (10) 0
Systems in use for BCG
documentation
N=107*** N=16
Antenatal/maternity records 43 (40) 5 (31)
Birth notification records 15 (14) 2 (12)
Paper log books held by
midwives
6 (6) 1 (6)
Child health information
system
100 (93) 14 (88)
School health records 27 (25) 5 (31)
GP 50 (46) 3 (19)
Red Book 103 (96) 16 (100)
Discharge letters 37 (35) 2 (12)
GP, general practitioner.
*Nine, **three and ***four missing values for those variables.
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(9%) to schoolchildren only and in the remaining PCTs
to both groups. HVs are most frequently involved in
identifying eligible preschool children (51/85, 51%).
GPs alone were mentioned by 3/85 (4%) PCTs but 33/
85 (36%) PCTs reported that both GPs and HV identify
eligible preschool children. A similar pattern was seen
for the identiﬁcation of school children: school nurses
alone identify eligible school children in 56/80 (70%)
PCTs, GPs alone in 9/80 (11%) PCTs and in 15/80
(19%) PCTs both school nurses and GPs identify school
children.
All PCTs offering vaccination outside infancy reported
assessing previous BCG immunisation in eligible chil-
dren using at least one of the criteria recommended by
the Green Book. Sixty-four of 94 (68%) PCTs use a com-
bination of reliable parental recall, documentary evi-
dence and presence of a scar as evidence of previous
BCG vaccination. Seventy of 94 (18%) PCTs use the
combination of a BCG scar and reliable recall; whereas
13/94 (14%) consider only one criterion as sufﬁcient
evidence.
Logistic constraints hindering BCG administration
Of all PCTs, 26/127 (20%) reported periods between
2005 and 2010 during which they could not administer
BCG due to logistic constraints. The most frequent
reasons are vaccine supply shortage and lack of trained
health workers (including access to training) to adminis-
ter the vaccine. One PCT reported various episodes
where no BCG could be administered as a result of a
pending business case over who was to carry out BCG vac-
cination when the previously appointed community
paediatrician retired. A similar problem was reported in a
different PCT reporting unclear responsibilities after the
adult respiratory department stopped seeing paediatric
patients. In one PCT, BCG could not be administered
over a 2-year period due to the absence of funding agree-
ments and was only reintroduced after a school outbreak.
DISCUSSION
Six years after its introduction, the 2005 recommenda-
tion for BCG vaccination has been implemented in the
vast majority of England PCTs. All surveyed PCTs have
an infant vaccination policy in place, but a quarter of
these PCTs do not report offering vaccination outside
infancy. Selective infant vaccination mostly takes place
on the postnatal ward and during the ﬁrst month of life
whereas universal infant vaccination mainly happens in
community clinics and after the ﬁrst month of life. In
PCTs with a selective infant vaccination policy, this
survey found greater variation in the organisation of
BCG vaccine delivery.
We were unable to gather information from 15% of
the PCTs. However, TB notiﬁcation rates between
responding and non-responding PCTs were similar, sug-
gesting results presented are not likely to be biased.
Since the JCVI issued their recommendations in 2005,
there has been an ongoing discussion about how to
deﬁne areas of high TB incidence in the context of the
policy.10–12 Universal infant vaccination is, for oper-
ational reasons, recommended in PCTs where the TB
incidence is ≥40 per 100 000 pyrs, as it is agreed that
this is the most efﬁcient way to reach all infants at high
risk of TB in such areas. Nevertheless, the cut-off inci-
dence for targeted infant vaccination is debated as chil-
dren in PCTs with an incidence <40 per 100 000 pyrs
can still be at high risk of TB.13
In this survey, six PCTs in or close to urban areas
reported vaccinating all infants, although their
PCT-speciﬁc incidence is <40 per 100 000 pyrs. This
could indicate that some PCTs in urban areas are consid-
ering regional incidence to inform their policies, rather
than PCT-speciﬁc incidence. Nevertheless, it remains
uncertain if this strategy ensures that the maximum
number of eligible children are being immunised, and if
it is more cost-effective than a PCT-speciﬁc informed tar-
geted vaccination policy. Further analysis of the economic
efﬁciency of regional BCG vaccination is required.
Surveys of BCG vaccination policies and practices in
England and Wales in 1982 and 1992 indicated consider-
able variations across health districts.14 15 In 1992, 15 of
the 186 health districts in England had already stopped
their routine school immunisation programme; 148
offered BCG to selected groups of neonates and ﬁve dis-
tricts routinely gave BCG to all their neonates.15 Today,
variation in local BCG vaccination policies is lower but
the organisation of BCG delivery remains highly vari-
able. We ﬁnd that PCTs commission a wide range of
healthcare providers to deliver the vaccine. This hetero-
geneity across PCTs also demands a high level of organ-
isation between PCTs if services such as maternity care
straddle PCT borders. Hospitals may not be
co-terminous with PCTs and hence infants from PCTs
with different policies and practices can be born in the
same hospital. In this light, it is of concern that many
PCTs do not have service-level agreements to organise
BCG administration either within the PCT or across
Table 3 Systems in use to flag up infants’ eligibility for
BCG vaccination stratified by main responsible for
identification in 111 Primary Care Trusts with targeted
infant vaccination
Systems used to
flag up eligibility
Identification
primarily by
midwives*
Identification
primarily by
GP, HV or
paediatrician*
N=51 N=38
Maternity records 43 (84%) 14 (37%)
Baby’s hospital notes 28 (55%) 18 (47%)
Red Book 25 (49%) 22 (56%)
Birth notification records 10 (20%) 6 (16%)
Child health information
system
10 (20%) 6 (16%)
*Twenty-two observations with missing data.
GP, general practitioner; HV, health visitor.
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boundaries.4 This and the complexity of managing a
localised service could also explain why some PCTs were
unable to deliver BCG during periods where service pro-
viders changed.
The commissioning of BCG may become more complex
if it becomes the responsibility of Clinical Commissioning
Consortia. In its current form, the suggested changes to
the NHS structure could lead to consortia responsible for
overlapping geographical areas. If services are not
commissioned across boundaries and responsibilities are
not clearly assigned, the current heterogeneity in policies
and practices could increase and seriously compromise
the targeted infant vaccination. Infant hepatitis B vaccin-
ation is another selective programme, being given to
infants of mothers screened antenatally and found to be
positive for hepatitis B carriage. It works best when there is
an identiﬁed person in each area, who is responsible for
coordinating the programme.16 This model should be
considered for the BCG programme.
While the structural organisation of the NHS poses
challenges for the 2005 recommendations, the imple-
mentation of a targeted vaccination policy is, in its self,
demanding.17 Hence, it is vital to monitor the imple-
mentation to assure high vaccination coverage. Good
data on BCG immunisation coverage are complicated to
assemble in PCTs with targeted infant vaccination where
the denominator is unclear. Data from audits, however,
show that vaccination coverage in areas with targeted
infant vaccination can be low18 and that even in PCTs
with high coverage, it can vary greatly between maternity
units19 and ethnic groups.20 We ﬁnd that a wide range
of healthcare professionals are involved in the identiﬁca-
tion of eligible children. It is therefore conceivable that
infants are not identiﬁed due to unclear responsibilities.
In addition, our ﬁndings suggest that some health pro-
fessionals involved in the BCG vaccination programme
might be unfamiliar with recommended eligibility cri-
teria; this could contribute to low coverage rates.21 A
standardised pathway to identify eligible infants, with
clear responsibilities and roles and regular training of
staffs involved, could contribute to high vaccination
coverage in PCTs with selective vaccination policy.22 23
In addition to the correct identiﬁcation of infants at
risk, assuring that the vaccine is administered is another
challenge of a targeted vaccination policy.17 22 Half of
the PCTs vaccinate on postnatal wards—a vaccine deliv-
ery pathway associated with high vaccination coverage in
local audits.22–24 The other half, however, vaccinate in a
community setting or clinics which in this survey was
associated with vaccination at an older age. The differ-
ent delivery pathways probably reﬂect local circum-
stances. Immunising newborns in postnatal wards may
be more optimal in conditions in which the workload is
manageable at that level, with either a relatively lower
number of eligible newborns or a sufﬁcient number of
skilled personnel to administer BCG. Vaccinating in the
community might be more effective in areas with higher
numbers of eligible newborn (especially if universal
BCG vaccination) and limited number of trained staffs
to administer the vaccine in postnatal wards. However,
the latter could mean a higher risk of attrition as
parents may not return their children to immunisation
appointments, as reported in previous audits.23 25 A
study in South London found that parents would be
more interested if the vaccine was accessible on a
‘drop-in’ basis from community clinics18 in such areas.
Another aspect that might affect efﬁcient delivery is
that the most commonly used systems for documentation
of BCG receipt are often not the systems used to ﬂag up
eligibility. Aligning the systems used to identify eligible
children with the system used to document BCG vaccin-
ation could be an effective way to ensure that identiﬁed
infants receive the vaccine and a means to estimate cover-
age.24 Also, BCG vaccination was not delivered with other
routine infant vaccinations possibly because of the need
for speciﬁc training for an intradermal vaccination. The
addition of BCG vaccination to offer of other routine
infant vaccinations in speciﬁc regions could be another
way of ensuring coverage of those at risk.
The 2005 BCG policy for the UK also recommends
vaccinating previously unvaccinated children who are at
high risk of TB. Despite the policy, a quarter of all PCTs
do not report vaccinating outside infancy. Although the
absence of vaccination outside infancy may conserve
resources in areas with low levels of migration, some
PCTs in urban centres with presumably high levels of
migration do not report vaccinating outside infancy.
This suggests that greater efforts are needed to
strengthen targeted BCG vaccination outside infancy.
In conclusion, a targeted infant BCG vaccination has
been implemented in most PCTs across England, either
as part of postnatal hospital care or a community vaccin-
ation programme separate from other childhood vacci-
nations via a number of locally agreed healthcare
professionals. Information to assess coverage would be
useful to monitor successful provision of an effective
measure to prevent childhood TB.
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